Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma?

Darren J. Fernandes, Richard W. Mitchell, Oren Lakser, Maria Dowell, Alastair G. Stewart, Julian Solway*

*Corresponding author for this work

Research output: Contribution to journalReview article

58 Scopus citations

Abstract

It is now accepted that a host of cytokines, chemokines, growth factors, and other inflammatory mediators contributes to the development of nonspecific airway hyperresponsiveness in asthma. Yet, relatively little is known about how inflammatory mediators might promote airway structural remodeling or about the molecular mechanisms by which they might exaggerate smooth muscle shortening as observed in asthmatic airways. Taking a deep inspiration, which provides relief of bronchodilation in normal subjects, is less effective in asthmatic subjects, and some have speculated that this deficiency stems directly from an abnormality of airway smooth muscle and results in airway hyperresponsiveness to constrictor agonists. Here, we consider some of the mechanisms by which inflammatory mediators might acutely or chronically induce changes in the contractile apparatus that in turn might contribute to hyperresponsive airways in asthma.

Original languageEnglish (US)
Pages (from-to)844-853
Number of pages10
JournalJournal of applied physiology
Volume95
Issue number2
DOIs
StatePublished - Aug 1 2003

Keywords

  • Actin
  • Airflow obstruction
  • Myosin

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma?'. Together they form a unique fingerprint.

  • Cite this